Watch How to Trade Teva Pharmaceutical - Bloomberg
Teva shares drop 18%, lose third of their value in two days - Business - Haaretz.com
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Israel's Teva offering free drugs to settle U.S. opiods case - Business - Haaretz.com
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case - Bloomberg Law
Glaxo/Teva Ruling Could Spell Trouble for Generic Drugmakers
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva's $225 Million Opioid Deal With Texas Is Its Biggest (2)
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Watch Mylan Board Rejects $40.1B Teva Takeover Bid - Bloomberg
